Oxford start-up seeks financing for stomach cancer breath test
This article was originally published in Clinica
Executive Summary
UK start-up Oxford Micro Medical is looking to raise £100,000 ($150,000) from external investors to help advance the development of its handheld, point-of-care breathalyzer for diagnosing stomach cancer. The device, called NanoBreath, will incorporate mass spectrometry technology originally intended for use in space exploration and the finished product will be significantly cheaper, more compact and simpler to use than current instrumentation used in breath tests for stomach cancer.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.